Zobrazeno 1 - 4
of 4
pro vyhledávání: '"35"'
Autor:
Karl-Ludwig Neuhaus, Jarosław Wójcik, Liane Gläsle-Schwarz, P. Tanswell, Ulrich Tebbe, Erhard Seifried
Publikováno v:
Journal of the American College of Cardiology. 19(5):1071-1075
Pharmacokinetics and fibrin specificity of alteplase (recombinant tissue-type plasminogen activator) were determined in 10 patients with acute myocardial infarction undergoing an accelerated infusion regimen during the alteplase/anistreplase patency
Autor:
Walter Niederer, Ulrich Tebbe, Karl-Ludwig Neuhaus, Susanne Jeep-Tebbe, Werner Feuerer, A. Vogt
Publikováno v:
Journal of the American College of Cardiology. 14(6):1566-1569
To improve further the patency rate of infarct-related coronary arteries, the following accelerated dosage regimen of recombinant tissue-type plasminogen activator (rt-PA) was administered to 80 patients with acute myocardial infarction of less than
Autor:
Rainer von Essen, A. Vogt, Klaus Haerten, Wolfgang Maeurer, Florian Forycki, Wolfgang Merx, Michael Riess, Ulrich Tebbe, Walter Niederer, Michael Roth, Peter Limbourg, Alexander Wirtzfeld, Karl-Ludwig Neuhaus
Publikováno v:
Journal of the American College of Cardiology. (5):885-891
Thrombolysis with recombinant tissue-type plasminogen activator (rt-PA) and anisoylated plasminogen streptokinase activator (APSAC) in myocardial infarction has been proved to reduce mortality. A new front-loaded infusion regimen of 100 mg of rt-PA w
Publikováno v:
Journal of the American College of Cardiology. (6):1212-1220
To delineate the role of plasmin inhibitors, especially the two molecular forms of α2-antiplasmin (that is, the plasminogen-binding and the nonplasminogen-binding forms), in the control of systemic effects during thrombolytic therapy, the consumptio